AAD 2025
We had so many great conversations at AAD 2025 – among them shared insights and solutions with the dedicated folks at PPD Thermo Fisher Scientific
Introducing LAMA
Thacolan is excited to announce our new, innovative software, LAMA! The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials.
Disease State Image Sourcing
Thalocan maintains a library of disease state images across many dermatological indications. This includes common diseases such as atopic dermatitis and psoriasis and less common diseases such as vitiligo, alopecia, ichthyosis, urticaria and sub indications such as plantar psoriasis and hand eczema. Beyond our library, Thalocan can leverage our global network of experts to source…
Details
Great to be back at SCOPE!
It was great to be back at SCOPE Summit and see old friends, still working to support the research community and bring much-needed therapies to patients.
Introducing TAVOS
Thalocan is excited to introduce our cloud application TAVOS!
Custom 3d Animation Services
Thalocan is now making our 3D animation services available for your custom needs! Our skilled team is ready to bring your ideas to life with tailored visuals that meet your specific needs.
WEBINAR: FDA Diversity Guidance and Unmet Needs in Outcome Measures
View Thalocan CEO Eric Zudak’s presentation to the New York SOCRA Chapter examining the challenges with endpoints as it relates to enrollment diversity in dermatology trials. View Webinar
Details